down arrow

NewAmsterdam Pharma Co. NV

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL00150012L7
USD
35.85
-2.48 (-6.47%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Sep'22
Net Sales
19.14
2.98
12.77
29.11
2.28
1.40
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
19.14
2.98
12.77
29.11
2.28
1.40
0.00
Raw Material Cost
0.04
0.05
0.05
0.03
0.02
0.01
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
9.90
10.16
7.65
5.45
9.59
13.05
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
27.22
27.10
21.05
17.75
16.10
13.91
2.29
Other Expenses
1.76
3.46
2.72
3.03
2.88
2.94
0.00
Total Expenditure (Excl Depreciation)
54.78
71.90
56.00
53.48
54.49
56.35
2.29
Operating Profit (PBDIT) excl Other Income
-35.6
-68.89999999999999
-43.2
-24.4
-52.199999999999996
-55
-2.3000000000000003
Other Income
15.68
11.64
-3.38
9.12
3.88
0.67
0.71
Operating Profit (PBDIT)
-19.91
-57.23
-46.56
-15.21
-48.32
-54.27
-1.59
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
2.59
17.75
-45.56
-1.41
9.33
-39.48
-3.19
Gross Profit (PBDT)
19.10
2.93
12.72
29.08
2.26
1.39
0.00
Depreciation
0.04
0.05
0.05
0.03
0.02
0.01
0.00
Profit Before Tax
-17.36
-39.53
-92.18
-16.65
-39.01
-93.77
-4.78
Tax
0.00
0.00
0.00
-0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-17.36
-39.53
-92.18
-16.65
-39.01
-93.77
-4.78
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-17.36
-39.53
-92.18
-16.65
-39.01
-93.77
-4.78
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-17.36
-39.53
-92.18
-16.65
-39.01
-93.77
-4.78
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.12
0.12
0.0
Reserves
778.50
777.36
757.50
378.86
387.44
411.80
127.07
Earnings per share (EPS)
-0.15
-0.34
-0.95
-0.18
-0.41
-1.06
-0.27
Diluted Earnings per share
-0.15
-0.34
-0.95
-0.18
-0.41
-1.06
-0.27
Operating Profit Margin (Excl OI)
-186.13%
-2314.47%
-338.47%
-83.69%
-2291.14%
-3922.27%
0.0%
Gross Profit Margin
-90.46%
-1325.55%
-721.31%
-57.09%
-1710.75%
-6691.79%
0.0%
PAT Margin
-90.7%
-1327.3%
-721.71%
-57.18%
-1711.58%
-6692.86%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Markets Mojo
Analysis not available
Compare Quarterly Results Of NewAmsterdam Pharma Co. NV With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
19.14
21.36
-2.22
-10.39%
Other Operating Income
0.00
0.00
0.00
Total Operating income
19.14
21.36
-2.22
-10.39%
Raw Material Cost
0.04
9.11
-9.07
-99.56%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
9.90
0.00
9.90
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
10.99
-10.99
-100.00%
Selling and Distribution Expenses
27.22
19.88
7.34
36.92%
Other Expenses
1.76
4.46
-2.70
-60.54%
Total Expenditure (Excl Depreciation)
54.78
84.59
-29.81
-35.24%
Operating Profit (PBDIT) excl Other Income
-35.64
-63.23
27.59
43.63%
Other Income
15.68
3.40
12.28
361.18%
Operating Profit (PBDIT)
-19.91
-55.97
36.06
64.43%
Interest
0.00
10.99
-10.99
-100.00%
Exceptional Items
2.59
0.00
2.59
Gross Profit (PBDT)
19.10
12.24
6.86
56.05%
Depreciation
0.04
3.90
-3.86
-98.97%
Profit Before Tax
-17.36
-70.87
53.51
75.50%
Tax
0.00
0.00
0.00
Provisions and contingencies
0
0
0.00
Profit After Tax
-17.36
-70.87
53.51
75.50%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-17.36
-70.87
53.51
75.50%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-17.36
-70.87
53.51
75.50%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
778.50
213.68
564.82
264.33%
Earnings per share (EPS)
-0.15
-1.38
1.23
89.13%
Diluted Earnings per share
-0.15
-1.38
1.23
89.13%
Operating Profit Margin (Excl OI)
-186.13%
-296.26%
0.00
110.13%
Gross Profit Margin
-90.46%
-313.53%
0.00
223.07%
PAT Margin
-90.70%
-331.81%
0.00
241.11%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales NA Million
in

Figures in Million
stock-summary

stock-summary

Quarterly - Standalone Net Profit
Standalone Net Profit NA Million
in

Figures in Million
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) NA Million
in

Figures in Million
Quarterly - Interest
Interest NA Million
in

Figures in Million
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) NA%
in

Figures in %
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."